2018 年妇产与有性药学全球性代表次大会 (GORM 2018) 将于 2018 年 1 月 5-7 日在泰国仰光召开。本届次大会将继续遵循学术性性、全球性性的原则,特邀国内妇产与有性药学教育领域内的汉学家药学专家前来应邀出席,并做精彩的年度报告。本次次大会旨在为行业内药学专家和汉学家互动技术退步和该公司方面,聚焦妇产与有性药学研究教育领域的前沿研究,提供者一个学术交流的网络服务。 2018 年妇产与有性药学全球性代表次大会是由工程信息美国哈佛大学、科学研究再版社、千人新闻网站等单位联合协办,在教育领域内享受传奇色彩的全球性学术性研讨之一。此次代表次大会议题涵括妇产与有性药学,旨在充分运用连串学术交流互动月所科技成果和研究方式的学术性嘉年华会! 此次研讨将于 2018 年 1 月 5-7 日在泰国仰光召开,诚邀各位药学专家和代表的出席。
演讲来宾
rof. Rohan D'Souza, University of Toronto, Canada
rof. Arup Ratan Bandyopadhyay, UNIVERSITY OF CALCUTTA, India
rof. Valeria Sandrim, Universidade do Estado de São Paulo, Brazil
rof. Michael Chapman, University of New South Wales, Australia
篇文章再版
所有被代表次大会录用的英文稿件则会发表在科学研究再版社的开源医学期刊 "Journal of Biosciences and Medicines" (ISSN:2327- 5081)。如果您只是应邀出席则有年度报告,不无需发文,您只无需将您的概要提交到投稿系统。
应邀出席价格
ackage A: 只能应邀出席(无年度报告) USD 400 (RMB 2400) ackage B: 应邀出席 + 概要年度报告 USD 450 (RMB 2700) ackage C: 应邀出席 + 百字发表 + 年度报告 USD 600 (RMB 3600)
未公开
联系人: 张老师 Email: medi_dec@engii.org (Rolinrolin@126.com)电话: +86 150 7134 3477QQ: 3025797047微信公众号: Engii_hw
大代表次大会题
本次全球性研讨聚焦妇产与有性药学相关教育领域的前沿研究,旨在为行业内药学专家和汉学家互动技术退步和该公司方面提供者一个学术交流的网络服务。 该代表次大会征文局限教育领域最主要(但不局限):
Gynecology and ObstetricsMaternal Fetal Healthrenatal DiagnosisMidwiferyMedical Disorders in PregnancyHigh Risk PregnancyAssessment of Fetal Wellbeingeonatal CareClinical ObstetricsAntenatal and Postnatal CareOperative ObstetricsAddressing Maternal MortalityRole of MidwiferyGeneral Gynecologyediatric and Adolescent GynecologyGynecological Care for the Older Womanenign Conditions in GynecologyInfections in Obstetrics and GynecologyImaging in Obstetrics and GynecologyOperative GynecologyConventional Gynecological SurgeryGynecological Endoscopyafe Surgical Techniques and PracticesUrogynaecologyGenital ProlapseGynecological OncologyGynecological MalignanciesCervicitisUterine fibroidImplement current acog guidelines for pap smearsDiagnose and treat patients with endometriosis related painUse ultrasound to evaluate abnormal uterine bleedingDiagnose and manage polycystic ovarian syndromeractice of GynecologyGynecological EndocrinologyEpidemiology in Obstetrics and GynecologyMenopauseOperative GynecologyHealth-Related Behiors in WomenWomen’s Health Issues and PolicyMedical EducationEthics and Law in Gynecological PracticeInformation Technology in GynecologyReproductive MedicineAndrology Embryology exual Medicine exually Transmitted Diseases and Infections (STD/STI) Reproductive Endocrinology and Infertility (REI)Gametogenesis, Fertilization, Embryogenesis IVF/ICSI Organizations and Services Ovarian Stimulation Fertility Preservation and Enhancement Family Planning re-conception Health regnancy Contraception and Contraceptives Reproductive Health and Abortion Genetic Screening and Testing Reproductive System Diseases Ethical issues with ivf and surrogacyRisks and desired outcome in ivfImproving results in ivf and male factor infertilityLuteal phase support and recurrent abortionsasic laboratory and clinical aspects of art: clinical –biologicalImproving oocytes and embryo selectionreimplantation genetic screening (pgs) to prioritize embryo transferoor response to ovarian stimulationEndometriosis iological and Clinical Research Education and Training Ethics and Social IssuesOther Related Topics
主编:姚俊华相关新闻
相关问答